2008 Volume 55 Issue 12 Pages 612-618
Hypsiziprenol A9 is a polyterpene isolated from the fruiting body of the Japanese edible mushroom Buna-shimeji (Hypsizigus marmoreus). Although our recent studies revealed that hypsiziprenol A9 has strong anti-tumor activity against tumor-bearing mice, its mechanism of action remains unclear. To elucidate further its anti-tumor action, we examined in detail hypsiziprenol A9-induced apoptosis in human cancer cell lines.
We observed that hypsiziprenol A9 strongly inhibited the growth of human promyelocytic leukemia HL-60 cells and several other cancer cell lines in a dose-dependent manner. Hoechst 33342 staining showed DNA fragmentation and condensation of chromatin in HL-60 cells treated with hypsiziprenol A9. DNA laddering, a hallmark of apoptosis, was detected using agarose gel electrophoresis. In addition, flow cytometric analysis confirmed that hypsiziprenol A9 increased sub-G1/G0 populations in a time-dependent manner. Hypsiziprenol A9 also increased activities of caspase-2, -3, -8 and -9 in a dose-dependent manner in the apoptotic HL-60 cell. Furthermore, JC-1 fluorescent staining determined that hypsiziprenol A9-induced apoptosis was associated with a loss of mitochondrial membrane potential.
These results suggest that hypsiziprenol A9 inhibits the growth of HL-60 cells by inducing apoptosis that is mediated through mitochondrial membrane potential loss and caspase activation.
